Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Ottawa, Feb. 11, 2026 (GLOBE NEWSWIRE) -- The global RNA analysis market size will grow from USD 9.31 billion in 2025 to nearly USD 23.39 billion by 2035, with a significant CAGR of 9.65% from 2026...
-
PURCHASE, N.Y., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative...
-
Global Graphene Quantum Dot Market Size, Share, Trends & Segmentation by type, synthesis method, application, end user, and Region | Forecast 2025-2035
-
ARLINGTON, Va. and HERNDON, Va., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Two Six Technologies, a high-growth technology company dedicated to providing products and expertise to national security...
-
PURCHASE, N.Y., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative...
-
Chicago, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The global generative AI in Insurance market size was valued at USD 1.11 billion in 2025 and is projected to hit the market valuation of USD 14.35 billion...
-
Hyderabad, India, Jan. 20, 2026 (GLOBE NEWSWIRE) -- According to Mordor Intelligence, the genome editing market size was valued at USD 10.60 billion in 2025 and projected to grow from USD 12.29...
-
Lewes, Delaware, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The Global Aviation Analytics Market Size is projected to grow at a CAGR of 11.40% from 2026 to 2032, according to a new report published by...
-
PURCHASE, N.Y., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX), today announced that a manuscript entitled, “Phase 2 Study of Zervimesine (CT1812) in Participants...
-
FDA grants AXS-05 Priority Review designation and sets PDUFA action goal date of April 30, 2026 NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a...